Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lori Styles, MD
Summit Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, Los Angeles (ucla) David Geffen School of Medicine
Los Angeles, California, United States
- Children'S Hospital Orange County
Orange, California, United States
- Continental Clinical Research
Miami, Florida, United States
- D&h National Research Centers
Miami, Florida, United States
- Dynamic Medical Research Llc
Miami, Florida, United States
- Hmd Research
Orlando, Florida, United States
- Children'S Center for Digestive Health
Atlanta, Georgia, United States
- Snake River Research
Idaho Falls, Idaho, United States
- Ann and Robert H Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- University of Chicago - Comer Children'S Hospital
Chicago, Illinois, United States
- Indiana University Health - Riley Hospital for Children
Indianapolis, Indiana, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- Children'S Hospital of Michigan
Detroit, Michigan, United States
- Digiovanna Institute for Medical Education and Research
New York, New York, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Stony Brook University Medical Center
Stony Brook, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- University Hospitals Cleveland Medical Center - Rainbow Babies and Children'S Hospital
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 May 2021
- Primary completion
- 17 Sept 2021
- Completion
- 28 Sept 2022
- Last update posted
- 21 Aug 2023
- Registered enrollment
- 2
- Registry id
- NCT04802837
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.